Functional assays for the assessment of the pathogenicity of variants of GOSR2, an ER-to-Golgi SNARE involved in progressive myoclonus epilepsies. by Völker, J.M. et al.
RESEARCH ARTICLE
Functional assays for the assessment of the pathogenicity of
variants of GOSR2, an ER-to-Golgi SNARE involved in
progressive myoclonus epilepsies
Jörn M. Völker1, Mykola Dergai2, Luciano A. Abriata3,4, Yves Mingard2, Daniel Ysselstein5, Dimitri Krainc5,
Matteo Dal Peraro3,4, Gabriele Fischer von Mollard1, Dirk Fasshauer2, Judith Koliwer1,* and
Michael Schwake1,5,*
ABSTRACT
Progressive myoclonus epilepsies (PMEs) are inherited disorders
characterized by myoclonus, generalized tonic-clonic seizures,
and ataxia. One of the genes that is associated with PME is
the ER-to-Golgi Qb-SNARE GOSR2, which forms a SNARE
complex with syntaxin-5, Bet1 and Sec22b. Most PME patients
are homozygous for a p.Gly144Trp mutation and develop
similar clinical presentations. Recently, a patient who was
compound heterozygous for p.Gly144Trp and a previously unseen
p.Lys164del mutation was identified. Because this patient presented
with a milder disease phenotype, we hypothesized that the
p.Lys164del mutation may be less severe compared to p.Gly144Trp.
To characterize the effect of the p.Gly144Trp and p.Lys164del
mutations, both of which are present in the SNARE motif of GOSR2,
we examined the corresponding mutations in the yeast ortholog
Bos1. Yeasts expressing the orthologous mutants in Bos1 showed
impaired growth, suggesting a partial loss of function, which was
more severe for the Bos1 p.Gly176Trp mutation. Using anisotropy
and gel filtration, we report that Bos1 p.Gly176Trp and p.Arg196del
are capable of complex formation, but with partly reduced activity.
Molecular dynamics (MD) simulations showed that the hydrophobic
core, which triggers SNARE complex formation, is compromised due
to the glycine-to-tryptophan substitution in both GOSR2 and Bos1.
In contrast, the deletion of residue p.Lys164 (or p.Arg196del in
Bos1) interferes with the formation of hydrogen bonds between
GOSR2 and syntaxin-5. Despite these perturbations, all SNARE
complexes stayed intact during longer simulations. Thus, our data
suggest that the milder course of disease in compound
heterozygous PME is due to less severe impairment of the
SNARE function.
KEY WORDS: Progressive myoclonus epilepsies, PME, GOSR2,
Membrin, GS27, Bos1
INTRODUCTION
Subcellular trafficking of membranes and their associated proteins
is essential for proper function of eukaryotic cells. Fission from
donor membranes and fusion of transport vesicles with target
membranes allows for controlled transport of cargo, including
lipids, proteins, and cellular messengers such as hormones. SNARE
[soluble NSF (N-ethylmaleimide-sensitive factor) attachment
protein receptor] proteins, with their highly conserved SNARE
domains, are a main component of the fusion process. Four different
SNARE domains found on vesicles and target membranes interact
to form a quaternary SNARE complex providing the driving force
necessary for membrane fusion (Jahn and Scheller, 2006). The
SNARE complex structure is defined by a twisted parallel bundle of
four helices (Sutton et al., 1998). The contacting surfaces of these
helices can be separated into 16 layers, which are indicated by
numbers from −7 to +8 (Fig. 1). These layers are mainly
hydrophobic, except for the hydrophilic 0-layer in the center of
the bundle (Fasshauer et al., 1998). The complex usually consists of
three Q-SNAREs (Qa, Qb and Qc) and one R-SNARE, which
contain a glutamine or an arginine in the 0-position, respectively
(Fasshauer et al., 1998).
One of the earliest membrane fusion events in the secretory
pathway is the anterograde transport between endoplasmic
reticulum (ER) and Golgi. In this step, the Qb-SNARE GOSR2,
also referred to as membrin or GS27, forms a complex with the Qa-
SNARE syntaxin-5, the Qc-SNARE Bet1 and the R-SNARE
Sec22b (Hay et al., 1997; Lowe et al., 1997). This SNARE complex
mediates several fusion processes between the ER, the ER-Golgi
intermediate compartment (ERGIC) and the Golgi (Hay et al.,
1998). The importance of GOSR2 in these processes is supported by
the observations that knockdown of GOSR2 leads to a significant
decrease in transport from ER to Golgi and interferes with Golgi
maintenance (Gordon et al., 2010; Lowe et al., 1997). The
structural, kinetic and regulatory mechanisms of the complex
formation are unknown, although it is likely that the R-SNARE
Sec22b interacts with a preformed ternary complex of all three Q-
SNAREs (Xu et al., 2000). It is also likely that this process is highly
regulated: studies with yeast SNAREs in vitro have revealed that
membrane fusion occurs only when Bet1 is located on a donor
membrane and its SNARE partners are on an acceptor membrane
(Parlati et al., 2000).
Mutations in GOSR2 are associated with progressive myoclonus
epilepsies (PMEs), characterized by myoclonus, generalized tonic
clonic seizures, and ataxia (Berkovic et al., 1986). A group of PMEReceived 21 December 2016; Accepted 2 October 2017
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patients has been identified to possess a homozygous mutation of
c.430G>T in the gene encoding for GOSR2 on chromosome 17,
resulting in a p.Gly144Trp substitution in the protein. Glycine 144
is localized in the conserved SNARE domain of the protein. This
homozygous mutation was first detected in a PME patient with
severe motor disturbance with no described development of
dementia. However, upon autopsy, a slightly reduced weight of
the brain was measured and minor loss of Purkinje cells and
gliosis in the cerebellar vermis were detected (Corbett et al.,
2011). With time, 11 more patients were found to possess the
p.Gly144Trp variant of GOSR2. The syndrome was called ‘North
Sea PME’ given the fact that all patients originated from countries
surrounding the North Sea (Boisse Lomax et al., 2013). These
patients shared a similar phenotype, with an onset of ataxia of about
2 years, onset of myoclonic seizures of about 6.5 years and scoliosis
by adolescence. The patients also do not display significant
intellectual disability or cognitive dysfunction until late in disease
progression.
Recently, a case of PME was reported in a female patient with
compound heterozygous mutations in the gene encoding for
GOSR2 (Praschberger et al., 2015). This patient carried the
already described p.Gly144Trp mutation on one allele, whereas
the other allele carried a previously unseen in-frame deletion of
three base pairs, c.491_493delAGA. This deletion results in loss
of a lysine (p.Lys164del) located within the SNARE domain of
GOSR2. The respective patient was 61 years old and displayed a
rather mild disease course with only mild cognitive dysfunction
compared to patients homozygous for the p.Gly144Trp mutation.
These observations suggest that the deletion of the lysine residue
at position 164 has less severe functional consequences than the
p.Gly144Trp mutation. Therefore, in this study we aimed to
understand the functional effect of the two PME-linked mutations in
GOSR2 and their influence on the stability and formation of the
SNARE complex necessary for ER-to-Golgi transport.
RESULTS
The deletion of arginine 196 in Bos1 leads to a partial loss of
function in yeast
The more mild disease course of the patient that is compound
heterozygous for the p.Gly144Trp and the p.Lys164del mutations in
GOSR2, and the lack of functional data on the p.Lys164del
mutation, prompted us to functionally characterize these mutations
in more detail. Both mutations reside in the SNARE domain of
GOSR2 (Fig. 1) and therefore possibly affect SNARE complex
assembly and/or function. The 16 layers of the SNARE domain of
GOSR2 display remarkably evolutionary conservation in the animal
kingdom and in the orthologous protein in fungi, called Bos1.
Sequence alignment of human GOSR2 and Bos1 from
Saccharomyces cerevisiae indicates conservation of the p.Gly144/
p.Gly176 and similarity of the p.Lys164/p.Arg196 amino acids
(Fig. 1). The p.Gly144/p.Gly176 residues are located within the −3
layer in the SNARE domain of both GOSR2 and Bos1, whereas the
p.Lys164/p.Arg196 residues reside between layer +2 and +3
(Fig. 1).
Fig. 1. SNARE motif sequence alignment of GOSR2 and its yeast ortholog, Bos1. The PME-associated mutations of GOSR2, p.Gly144 and p.Lys164, as
well as the yeast ortholog Bos1 p.Gly176 and p.Arg196, are located at highly conserved positions within the SNARE motif. GOSR2 and Bos1 contain an N-
terminal Habc domain, a SNARE motif and a transmembrane domain (TM) at the C-terminus. Sequence alignments of SNARE proteins of over 200 animals or
fungi are presented as weblogo and show the high sequence conservation of the SNARE domain (Crooks et al., 2004). GOSR2 and Bos1 share high sequence
similarity. The SNAREmotif consists of 16 hydrophobic layers, as indicated. The p.Gly144 and p.Gly176 mutations are located at the −3 layer, whereas p.Lys164
and p.Arg196 are located between layers +2 and +3 (Kloepper et al., 2007).
Abbreviations and nomenclature
PMEs Progressive myoclonus epilepsies
GOSR2 Golgi SNAP receptor complex member 2
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To investigate the functionality of the p.Gly176Trp and the
p.Arg196del mutations in Bos1, we used a negative selection assay
as described previously (Corbett et al., 2011). Because the bos1Δ
strain of S. cerevisiae is not viable, a BY4742 wild-type strain was
transformed with pRS316-BOS1 followed by BOS1 deletion to
generate the endogenous bos1Δ knockout. Transformation with
pRS315 plasmids encoding for Bos1 wild-type or Bos1 mutants
followed by plating on media containing 5-fluoroorotic acid
(5-FOA) allows for selection against pRS316 (Fig. 2A).
Expression of the Bos1 p.Gly176Trp mutant completely
perturbed growth after 48 h and conferred only a little growth
after 72 h when compared to wild-type Bos1, indicating a very
severe but not complete loss of function, as was reported previously
(Corbett et al., 2011). Next, we substituted the glycine residue at
position 176 for a hydrophilic aspartate to test the importance of the
presence of a hydrophobic amino acid in the −3 layer. Yeasts
expressing the p.Gly176Asp mutation also displayed complete
perturbation of growth, suggesting that either a bulky hydrophobic
or a hydrophilic amino acid at this position severely affects Bos1
function (Fig. 2A). By contrast, examination of the deletion of
Fig. 2. The effect of Bos1 mutations on yeast growth. (A) Bos1 p.Gly176Trp, p.Gly176Asp and p.Arg196del show growth impairment compared to Bos1 wild
type. The yeast strain BY4742 bos1Δ containing pRS316-BOS1 was generated as previously described (Corbett et al., 2011) and transformed with pRS315
plasmids expressing Bos1 wild type or Bos1 mutants. URA3, which is only present on the pRS316 plasmid, converts 5-fluoroorotic acid (5-FOA) to cytotoxic
5-fluorouracil. Plating yeast cells on media containing 5-FOA allows for negative selection regarding RS316. Only cells that express a functional Bos1
protein and lack pRS316 can thrive on 5-FOA-containing media. Indicated strains were spotted on SD-Leu/Ura and 5-FOA plates with serial dilutions (1:10) and
incubated at 30°C for 48 h. Cells transfected with pRS315-bos1-p.Arg196del showed impaired growth compared to pRS315-BOS1 wild-type strains; however,
pRS315-bos1-p.Gly176Trp and -p.Gly176Asp led to severe impairment, indicating a functional impairment of the Bos1 p.Arg196del mutant and even
stronger impairment of the Bos1 p.Gly176Trp and p.Gly176Asp variants. (B) Temperature-sensitive (ts) strain of S. cerevisiae was transformed with different
variants of Bos1. At room temperature, growth was detected for all variants, including the negative control. At 24°C, reduced growth was detected for Bos1
p.Gly176Trp and p.Gly176Asp; only a few remaining colonies were detected for the negative control. At 30°C, only the wild type and the p.Arg196del enabled the
yeast to grow. Finally, at 37°C, also yeasts transformed with the p.Arg196del variant lacked the ability to grow completely.
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arginine 196 revealed only a slight growth perturbation after 48 and
72 h, indicating a less severe loss of function for this mutation.
To analyze the severity of these mutations on yeast growth more
precisely and to avoid toxic side effects of 5-FOA, we transformed a
temperature-sensitive yeast strain with the different Bos1 variants
(Andag et al., 2001). At 24°C, the negative control showed reduced
growth due to temperature sensitivity, whereas expression of wild-
type Bos1 was able to rescue growth (Fig. 2B). Examination of
yeasts expressing the p.Gly176Trp or the p.Gly176Asp mutation
revealed significantly less growth than the strain carrying wild-type
Bos1. The p.Arg196 deletion conferred comparable growth to the
yeast strain transformed with wild-type Bos1 at 24°C. Increasing the
temperature to 30°C resulted in an almost complete defect in growth
of yeasts expressing the −3 layer mutations p.Gly176Trp or
p.Gly176Asp, whereas only a slight decrease of growth for yeast
carrying the p.Arg196 deletion was detected relative to wild type
(Fig. 2B). Furthermore, at 37°C, yeasts expressing the p.Arg196del
mutation displayed defective growth, whereas yeasts transformed
with wild-type Bos1 were still able to thrive. Next, we aimed to
analyze whether p.Lys164 and p.Arg196, in GOSR2 and Bos1,
respectively, behaved similarly. Additionally, we wanted to
examine whether an amino acid with a smaller side chain
(p.Gly176Ala; rather than a large Trp or Asp) in the −3 layer can
be tolerated. Therefore, we expressed Bos1 p.Arg196Lys and
p.Gly176Ala variants in the temperature-sensitive Bos1 strain and
detected similar growth for both variants and wild-type Bos1
(Fig. S1), strongly suggesting that these amino acid substitutions are
functionally redundant at these positions.
Altered assemblies of SNARE complexes containing the
Bos1 p.Gly176Trp or p.Arg196del mutations
The reduced, but not complete, loss of function of the mutant Bos1
p.Gly176Trp and p.Arg196del in yeast growth experiments suggests
that SNARE complex function is impaired but likely not completely
abolished. Because SNARE complex assembly is a prerequisite for
SNARE-mediated fusion of membranes, we analyzed the assembly
properties of the ER-to-Golgi SNARE complex formed by Bos1,
Bet1, Sed5 and Sec22 using fluorescence anisotropy measurements
and size exclusion chromatography (SEC). We then compared the
assembly behavior of the complex carrying wild-type Bos1 to
complexes containing the Bos1 p.Gly176Trp and p.Arg196del
mutations. SEC experiments revealed that both the wild-type Bos1
or the Bos1 SNARE domains carrying either of the two PME-
associated mutations, p.Gly176Trp or p.Arg196del, or the designed
p.Gly176Asp mutation, were able to assemble into complexes
(Fig. S2). To examine the kinetics of Bos1 p.Gly176Trp and
p.Arg196del assembling with Sec22, Sed5 and Bet1, we used
fluorescence anisotropy measurements. This analysis allows the
examination of SNARE complex formation in vitro using the isolated
SNARE domains only, as described previously (Demircioglu et al.,
2014). As expected, an increase of anisotropy of the labeled SNARE
domain of Sec22 upon mixing with the SNARE domains of the
respective complex partners (Bet1, Sed5 and Bos1) was detected,
demonstrating the kinetics of SNARE complex assembly (Fig. 3A).
Examination of the kinetics of complex formation for the
p.Arg196del mutant revealed a slower rate of assembly.
Interestingly, the p.Gly176Trp mutation induced a strongly
augmented rate of assembly compared with wild-type Bos1. Taken
together, these data indicate that both mutants are able to form
SNARE complexes (Fig. 3A). To further dissect the faster SNARE
complex formation kinetics of Bos1 carrying the p.Gly176Trp
mutation, we also analyzed the p.Gly176Asp mutation because this
substitution resulted in a similar attenuation of growth in yeast.
In contrast to the p.Gly176Trp variant, complex formation of
the Bos1 p.Gly176Asp variant was severely reduced when measured
by the fluorescence anisotropy assay (Fig. 3A). These data suggest
that the introduction of a hydrophilic amino acid at the p.Gly176
position has a profound effect on the speed of SNARE complex
assembly.
Next, we wanted to understand the faster kinetics of SNARE
complex assembly for the Bos1 p.Gly176Trp mutant. Therefore, we
analyzed the effects of Bos1 mutations on homo-oligomer assembly
using SEC of the purified SNARE domains. Analysis of the
p.Gly176Asp and p.Arg196del mutations revealed a significant
propensity to form oligomers, which was similar to wild-type Bos1.
In contrast the retention volume of Bos1, that of p.Gly176Trp
was largely increased (Fig. 3B), strongly suggesting that the
oligomerization capacity of p.Gly176Trp was significantly reduced.
These data suggest that the increased rate of SNARE complex
formation may be a result of the reduced propensity of the
p.Gly176Trp mutation to form homo-oligomers, thereby increasing
the number of monomeric Bos1 available for assembly.
In silico simulation of PME mutations in GOSR2/Bos1 reveal
disturbances in the SNARE complex
Our results indicate that Bos1 p.Gly176Trp and p.Arg196del are
able to assemble into SNARE complexes with Sed5, Sec22 and
Bet1, whereas the p.Gly176Asp mutation displayed severely
attenuated complex formation. Because there is no crystal
Fig. 3. ER-to-Golgi SNARE complex formation with Bos1 p.Arg196del.
(A) SNARE complex formation was measured by the increase of fluorescence
anisotropy as previously described (Demircioglu et al., 2014). For assembly,
500 nM OG-labeled Sec22 126-186C131OG were mixed with 2.7 µM Sed5 211-
320, Bet1 1-118 and Bos1 151-221 or its mutants. A slower increase in
fluorescence anisotropy indicates a reduced capability of Bos1 p.Arg196del to
form the ER-to-Golgi SNARE complex. Bos1 p.Gly176Asp shows an even
stronger effect. However, complex formation of Bos1 p.Gly176Trp seems to be
accelerated. (B) Size exclusion chromatography (SEC) was performed for the
individual SNARE domains of Bos1 variants. The Bos1 variants wild-type (wt),
p.Gly176Asp and p.Arg196del seemed to be present in a higher oligomeric
state than Bos1 p.Gly176Trp.
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Fig. 4. In silico simulation of the SNARE complexes bearing the two PME mutations. Molecular dynamics (MD) simulations suggest that the impact
on the SNARE complex of component proteins bearing mutated residues varies. (A) MD simulations of models of the quaternary yeast and human ER-to-Golgi
SNARE complexes revealed that the Gly144Trp mutation of GOSR2 as well as the orthologous Gly176Trp mutation of Bos1 interfered with the integrity of the
hydrophobic core of the helix bundle in the region surrounding layer −3, visible by an increase of the solvent-accessible surface area (SASA). Plotted are
independent MD replicas. (B) The deletion of Lys164 in GOSR2 or Arg196 in Bos1 led to a slight impairment of the hydrogen bond network between Qa- and
Qb-helices. On the right, relative hydrogen-bond occupancy for different hydrogen bonds between the neighboring Qa- and Qb-helices is reported for the different
models. The different hydrogen bonds are sorted based on their occupancy (hbond rank).
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structure available for this particular SNARE complex, we modeled
the quaternary yeast and human ER-to-Golgi SNARE complex
using available SNARE complex structures as template. These
homology models were then explored by MD simulations (Fig. 4).
Our results reveal that the wild-type model of the assembled
quaternary complexes remained stable within a 102 ns timescale, as
shown by root mean square deviation (RMSD) profiles (Fig. S3A).
Comparable results were obtained when we used existing X-ray
structures of SNARE complexes (data not shown), corroborating the
robustness of our SNARE complex models. We next simulated with
MD complexes carrying the Bos1 p.Gly176Trp or p.Arg196del
mutations and the human orthologs, which previous results have
shown to be capable of complex formation (Fig. S2). Both PME
mutations behaved similar to the wild-type protein, with both
showing similarly stable RMSD values, suggesting that the mutated
SNARE complexes are stable in the explored timescale (Fig. S3A).
Next, we analyzed secondary-structure alterations during
simulations. As depicted in Fig. S3B, the SNARE complex
bearing the Bos1 p.Gly176Trp mutation and the human ortholog
showed no strong alterations in secondary structure. However, we
observed small changes in the N-terminal region, bearing the
GOSR2 p.Gly144Trp mutation. In contrast, the complexes carrying
the Bos1 p.Arg196del or GOSR2 p.Lys164del mutation exhibited a
local loss of helical structure, likely due to the lack of helical
periodicity (Fig. S3B).
Although complexes containing mutated Bos1 or GOSR2
remained stable during prolonged MD simulations, the structures
appeared to exhibit local structural disturbances. We investigated
the regions immediately surrounding the mutations in more detail.
We noted that the −3 layer, containing the p.Gly176Trp exchange,
is highly asymmetric. In addition to the glycine from Bos1, the −3
layer is composed of a methionine from Sec22, a phenylalanine
from Sed5 and a serine from Bet1. As expected, the substitution of
the small and highly conserved glycine to a bulky tryptophan makes
it difficult to pack all four side chains of this layer into the core of the
complex. Our MD simulations reveal that adjacent residues
opposing Trp176 in the hydrophobic layer avoided steric clashes
and repeatedly evaded the hydrophobic core of −3 layer, getting
more solvent-accessible (Fig. 4A). Similar results were obtained for
the mutation of the −3 layer of the orthologous human complex,
which has the same amino acid composition (Fig. 4A). This
observation is consistent with our yeast growth experiments where
the substitution of glycine for another small residue, an alanine, did
not lead to growth impairment (Fig. S1), whereas substitution to a
large tryptophan led to a clear growth defect (Fig. 2).
The deletion of the arginine residue at position 196 of Bos1 or the
lysine residue at position 164 of GOSR2 had a different effect on the
assembled SNARE complex. Our MD simulations showed that the
deletion was surprisingly well tolerated in the assembled four-helix
bundle structure, although it produces a significant discontinuity of
the coiled-coil heptad repeat and tighter local winding (Fig. 4B). In
contrast to the Gly176Trp mutation, we did not observe a significant
change in the solvent-accessible surface area (SASA) of the adjacent
residues contributing to the hydrophobic core during simulations
(Fig. S3C). It is possible that the p.Arg196del mutation does not
affect the hydrophobic core of the complex, but instead changes the
arrangement of residues that shield the interior of the bundle and
alters hydrogen bonding. In the wild-type complex, the deleted
arginine residue at position 196 is involved in stable hydrogen bond
formation with an aspartate residue at position 299 in Sed5
(Fig. 4B). Comparison of the distribution of hydrogen bonds
between Bos1 and Sed5 showed that the hydrogen bond network
was affected by the deletion of the p.Arg196 residue, likely as a
result of reduced numbers of contacts between the two neighboring
SNARE helices (Fig. 4B).
In summary, we have shown, by using the orthologous yeast
ER-to-Golgi SNARE complex, that the pathogenic mutations
p.Gly144Trp and p.Lys164del in the Qb SNARE GOSR2 do not
interfere with general SNARE complex stability. However, the
p.Gly144Trp mutation in the−3 layer appears to disturb the stability
and solvent accessibility of the hydrophobic core of the SNARE
complex, whereas the p.Lys164del mutation perturbs hydrogen
bonding between GOSR2 and syntaxin-5. Finally, yeast growth
experiments demonstrate that the p.Gly144Trp mutation causes a
more severe phenotype than the p.Lys164del mutation, which
corresponds well with the progression of the disease in PME
patients. Thus, our data suggest that a combination of in silico and
yeast experiments can describe at a molecular level the assembly
and stability of variant SNARE complexes.
DISCUSSION
GOSR2 is a Qb-SNARE protein involved in ER-to-Golgi
trafficking, and is associated with PME. In the present study, we
investigated the functionality of the PME-associated GOSR2
mutations p.Gly144Trp and p.Lys164del using yeast orthologs.
Yeasts carrying the orthologous p.Arg196del mutation of Bos1
showed growth defects at elevated temperatures typical for a
temperature-sensitive strain. This finding suggests that the function
of mutated Bos1 and the orthologous mutation in GOSR2
p.Lys164del is impaired but not lost. In contrast, the Bos1
p.Gly176Trp (GOSR2 p.Gly144Trp) mutation led to a more
significant impairment of function in yeast as indicated by severely
impaired growth even at lower temperatures. These results are
consistent with the milder disease phenotype observed in the patient
carrying the compound heterozygous p.Lys164del and p.Gly144Trp
mutations, compared to patients homozygous for the p.Gly144Trp
mutation (Boisse Lomax et al., 2013; Praschberger et al., 2015).
Physical simulations of protein complexes indicate that the
p.Gly144Trp mutation affects the stability of the hydrophobic core,
which provides the driving force for SNARE complex formation.
The substitution of the small glycine to a large tryptophan causes
steric clashes that might interfere with assembly of the four-helix
bundle, but might also destabilize the entire complex, thereby
reducing its vesicle-fusion activity. Notably, the p.Gly144Trp
mutation is in close proximity to a site important for v-SNARE
binding (Pobbati et al., 2006; Wiederhold and Fasshauer, 2009).
Highly decelerated complex formation of p.Gly176Asp but
acceleration of the p.Gly176Trp variant is contrary to the
expectations for impaired SNARE function. However, we found
that the glycine-to-tryptophan substitution also changed the
oligomeric state of Bos1 in our in vitro assembly experiments.
Whereas the isolated SNARE domain of wild-type Bos1 was
present as an oligomer, which needs to dissociate first for SNARE
complex formation, Bos1 p.Gly176Trp was already present as a
reactive monomer. It is unlikely, though, that oligomerization of the
SNARE domain of Bos1 plays a role during SNARE complex
formation in vivo.
According to our data, microdeletion of lysine 164 did not affect
the hydrophobic core, but reduced the occupancy of particular
hydrogen bonds between Qa and Qb helices. This microdeletion led
to a slightly destabilized α-helix in the second half of the complex.
This has a less significant impact on complex assembly because the
N-terminal part contributes more to complex assembly (Pobbati
et al., 2006). This is supported by fluorescence anisotropy
1396
RESEARCH ARTICLE Disease Models & Mechanisms (2017) 10, 1391-1398 doi:10.1242/dmm.029132
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
measurements, which displayed only slightly slower complex
assembly of Bos1 p.Arg196del with its SNARE partners Sed5,
Bet1 and Sec22, compared to wild-type Bos1. The effect of the
deletion was far less severe than observed for the p.Gly176Asp
variant. Although the deletion does not impinge on the stability of
the hydrophobic core, it might still affect the membrane-fusion
activity of the assembled complex, because of the tighter local
winding of the Qb-helix close to the transmembrane region.
In summary, our study provides an analysis of PME-associated
GOSR2 mutations in silico and in vitro. We show that the milder
course of disease in a compound heterozygous PME patient for
GOSR2 p.Gly144Trp and p.Lys164del, when compared to
patients homozygous for GOSR2 p.Gly144Trp, is due to less
severe impairment of SNARE function by the p.Lys164del
mutations. We also investigated SNARE function at the
molecular level and showed that p.Gly144Trp interfered with the
SNARE hydrophobic core, whereas the p.Lys164del mutation
perturbed hydrogen bond formation between GOSR2 and
syntaxin-5. We propose that the observed SNARE complex
malfunction due to both mutations could result in impaired fusion
of ER- and ERGIC-derived vesicles with the cis-Golgi target
membrane, leading to a perturbation of ER-to-Golgi trafficking. In
neurons, the impairment of the early anterograde transport might
lead to disorders such as epilepsy due to alterations in the regulated
release of neurotransmitters, as well as the proper sorting of
neurotransmitter receptors at chemical synapses, providing a
possible link between mutations in GOSR2 and epilepsy
(Giannandrea et al., 2010; Multani et al., 1994).
MATERIALS AND METHODS
Materials
If not stated otherwise, chemicals were obtained from Merck (Darmstadt,
Germany), Roth (Karlsruhe, Germany), Thermo Fisher Scientific (Bremen,
Germany) or Sigma-Aldrich (Steinheim, Germany).
Yeast strains and negative selection with 5-FOA
Yeast strains and plasmids used in this study are described in Table S1. The
BY4742 bos1Δ strain was generated by transformation of BY4742 with
pRS316-BOS1. The resulting strain was transformed with bos1 deletion
cassettes produced by PCR to achieve the endogenous bos1 deletion as
previously described (Corbett et al., 2011). BY4742 bos1Δ strains
containing pRS316-BOS1 and pRS315 plasmids expressing Bos1, Bos1
p.Gly176Trp, Bos1 p.Gly176Asp or Bos1 p.Arg196del were grown for 12 h
in standard minimal medium with appropriate supplements (SD-Leu/Ura).
Equal ODs with serial dilutions (1:10) were plated on SD-Leu/Ura or SD-
Leu containing 5-FOA and incubated at 30°C for 48 h. Plating of the
indicated yeast strains on media containing 5-FOA allowed for negative
selection regarding pRS316.
Yeast strains and survival assay of temperature-sensitive yeast
strain
Yeast strains and plasmids used in this study are described in Table S1. The
temperature-sensitive (ts) yeast strain bos1 ts S32G-8A (Andag et al., 2001)
cannot thrive at 30°C or higher temperatures, unless a functional copy of bos1
is transformed and expressed. The bos1 ts strains containing pRS315 plasmids
expressing Bos1, Bos1 p.Gly176Trp, Bos1 p.Gly176Asp or Bos1 p.
Arg196del was grown for 12 h in standard minimal medium with
appropriate supplements (SD-Leu). Equal ODs with serial dilutions (1:10)
were plated on SD-Leu and incubated at 24, 30 or 37°C for 48 h or
room temperature for 72 h. Only yeast strains expressing a functional copy of
Bos1 can rescue the ts phenotype of the bos1 ts strain at 30°C and 37°C.
Protein constructs and purification
Plasmids used in this study are listed in Table S2. Unlike Bet1, only the
SNARE domains of Sed5, Sec22 and Bos1 were expressed. Single-cysteine
variants used in this study were designed as previously described
(Demircioglu et al., 2014). Recombinant proteins were expressed in
Escherichia coli strain BL21 (DE3) and purified by Ni2+-NTA
chromatography followed by ion exchange chromatography on an Äkta
system (GE Healthcare, Solingen, Germany). Depending on the pI of each
protein, MonoQ or MonoS was used as ion exchanger. Protein elution was
performed by using a linear gradient of NaCl in 20 mM Tris, pH 7.4 buffer
containing 1 mM EDTA and additionally 1 mM DTT for proteins carrying
cysteine residues. Hexa-His tags were removed before ion exchange
chromatography via thrombin cleavage. Protein concentrations were
determined by absorption at 280 nm or using Bradford assay.
Fluorescence anisotropy
Fluorescence measurements were performed in a spectrofluorometer
equipped with a second emission channel in T-configuration
(QuantaMaster 40, PTI, Birmingham, NJ). Sec22 126-186D131C was
labeled with Oregon Green (OG) 488 iodoacetamide according to the
manufacturer’s protocol and protein concentration determined via Bradford
assay. Experiments were carried out in 1-cm quartz cuvettes (Hellma,
Müllheim, Germany) in PBS buffer at 25°C. Measurement of fluorescence
anisotropy, which increases upon complex formation due to local flexibility
of the labeled residue, was carried out as previously described (Burkhardt
et al., 2008).
Size exclusion chromatography (SEC)
The oligomeric state of single proteins and quaternary SNARE complexes
was analyzed by SEC on a Superdex 75 column in PBS buffer containing
200 mM NaCl. Quaternary SNARE complexes consisting of Sed5 (211-
320), Bet1 (1-118), Sec22 (126-186) and one of the Bos1 (151-221) variants
were assembled with equal amounts of purified components and incubated
overnight in PBS buffer containing 200 mM NaCl. The molecular weight
was calculated with a standard containing Dextran blue, BSA, ovalbumin,
cytochrome c and aprotinin.
Modeling and MD simulations of the SNARE complexes
A set of crystal structures of different SNARE complexes (PDB ID codes
2NPS, 2GL2, 1SFC, 3B5N, 4WY4) was used as templates for modeling
(Welch et al., 2012). Models of human and yeast complexes were generated
withModeller v.9 (Sali and Blundell, 1993). Each complex was prepared for
simulations using the Leap module of AmberTools (Schafmeister et al.,
1995). Simulations were run with the NAMD engine (Phillips et al., 2005)
using the AMBER99SBildn force field (Hornak et al., 2006) and TIP3P
parameters for water (Jorgensen et al., 1983). Standard sodium and chloride
parameters from the AMBER force field were used. A conservative cutoff of
12 Å (Piana et al., 2012) was set for nonbonded interactions with a
switching function active between 10 and 12 Å. Electrostatics were treated
through particle-mesh Ewald summations with a grid spacing of 1 Å. Each
simulation box was minimized, equilibrated by Cα-restrained heating in
ten steps of 30 K up to 300 K for a total of 1 ns, and further equilibrated
by unrestrained heating. Subsequently, the production simulations were
carried out at 300 K and 1 atm, controlled with a Nosé–Hoover Langevin
piston.
Models of human and yeast complexes after unrestrained equilibration
were used as templates to generate corresponding mutant complexes. After
equilibration, all models were simulated for 90 ns. Because no significant
RMSD changes were observed after the first 50 ns, additional replicas were
only run for 60 ns. Each system was simulated in three replicas. Trajectories
were analyzed with VMD software modules and Tcl scripts. For hydrogen
bond contact measurements, a cutoff distance of 3.6 Å between heavy atoms
and an angle cutoff of 30° were used.
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